{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T22:29:59Z","timestamp":1721946599671},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12977-015-0199-8","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T08:41:32Z","timestamp":1439973692000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo"],"prefix":"10.1186","volume":"12","author":[{"given":"Masateru","family":"Hiyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazu","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Tateyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Kuramitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arya","family":"Biragyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,20]]},"reference":[{"key":"199_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481\u201392.","journal-title":"Blood"},{"issue":"6","key":"199_CR2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982;79(6):2031\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8488","key":"199_CR3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1(8488):1031\u20132.","journal-title":"Lancet"},{"issue":"8452","key":"199_CR4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2(8452):407\u201310.","journal-title":"Lancet"},{"issue":"3","key":"199_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1349-7006.1992.tb00092.x","volume":"83","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992;83(3):236\u20139.","journal-title":"Jpn J Cancer Res"},{"key":"199_CR6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","volume":"3","author":"M Iwanaga","year":"2012","unstructured":"Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol. 2012;3:322.","journal-title":"Front Microbiol"},{"issue":"2","key":"199_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmv.23181","volume":"84","author":"M Satake","year":"2012","unstructured":"Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84(2):327\u201335.","journal-title":"J Med Virol"},{"issue":"27","key":"199_CR8","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","volume":"28","author":"A Bazarbachi","year":"2010","unstructured":"Bazarbachi A, Plumelle Y, Carlos Ramos J, Tortevoye P, Otrock Z, Taylor G, et al. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol. 2010;28(27):4177\u201383.","journal-title":"J Clin Oncol"},{"key":"199_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-4690-10-91","volume":"10","author":"G Kchour","year":"2013","unstructured":"Kchour G, Rezaee R, Farid R, Ghantous A, Rafatpanah H, Tarhini M, et al. The combination of arsenic, interferon-alpha, and zidovudine restores an \u201cimmunocompetent-like\u201d cytokine expression profile in patients with adult T-cell leukemia lymphoma. Retrovirology. 2013;10:91.","journal-title":"Retrovirology"},{"issue":"Suppl 2","key":"199_CR10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF03165123","volume":"76","author":"K Yamaguchi","year":"2002","unstructured":"Yamaguchi K, Watanabe T. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol. 2002;76(Suppl 2):240\u20135.","journal-title":"Int J Hematol"},{"issue":"5","key":"199_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11912-013-0332-6","volume":"15","author":"A Mar\u00e7ais","year":"2013","unstructured":"Mar\u00e7ais A, Suarez F, Sibon D, Frenzel L, Hermine O, Bazarbachi A. Therapeutic options for adult T-cell leukemia\/lymphoma. Curr Oncol Rep. 2013;15(5):457\u201364.","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"199_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/aid.2007.9998","volume":"23","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Uozumi K, Taguchi H, et al. Nationwide Cohort Study of HTLV-1 Carriers in Japan: Joint Study on Predisposing Factors of ATL Development (JSPFAD) [abstract]. AIDS Res Hum Retroviruses. 2007;23(4):581\u2013600 (Abstract O-23).","journal-title":"AIDS Res Hum Retroviruses."},{"issue":"8","key":"199_CR13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211\u20139.","journal-title":"Blood"},{"issue":"23","key":"199_CR14","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","volume":"272","author":"T Imai","year":"1997","unstructured":"Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272(23):15036\u201342.","journal-title":"J Biol Chem"},{"issue":"3","key":"199_CR15","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","volume":"273","author":"T Imai","year":"1998","unstructured":"Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem. 1998;273(3):1764\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"199_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","volume":"11","author":"T Imai","year":"1999","unstructured":"Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999;11(1):81\u20138.","journal-title":"Int Immunol"},{"issue":"7","key":"199_CR17","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.177.7.4488","volume":"177","author":"K Hirahara","year":"2006","unstructured":"Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol. 2006;177(7):4488\u201394.","journal-title":"J Immunol."},{"issue":"5","key":"199_CR18","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","volume":"99","author":"O Yoshie","year":"2002","unstructured":"Yoshie O, Fujisawa R, Nakayama T, Harasawa H, Tago H, Izawa D, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood. 2002;99(5):1505\u201311.","journal-title":"Blood"},{"issue":"10 Pt 1","key":"199_CR19","first-page":"3625","volume":"9","author":"T Ishida","year":"2003","unstructured":"Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res. 2003;9(10 Pt 1):3625\u201334.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"199_CR20","doi-asserted-by":"crossref","first-page":"e6517","DOI":"10.1371\/journal.pone.0006517","volume":"4","author":"Y Yamano","year":"2009","unstructured":"Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D, et al. Abnormally high levels of virus-infected IFN-\u03b3+CCR4+CD4+CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One. 2009;4(8):e6517.","journal-title":"PLoS One"},{"issue":"8","key":"199_CR21","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1172\/JCI75250","volume":"124","author":"N Araya","year":"2014","unstructured":"Araya N, Sato T, Ando H, Tomaru U, Yoshida M, Coler-Reilly A, et al. HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells. J Clin Invest. 2014;124(8):3431\u201342.","journal-title":"J Clin Invest"},{"issue":"2","key":"199_CR22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.180.2.931","volume":"180","author":"K Hieshima","year":"2008","unstructured":"Hieshima K, Nagakubo D, Nakayama T, Shirakawa AK, Jin Z, Yoshie O. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol. 2008;180(2):931\u20139.","journal-title":"J Immunol"},{"issue":"2","key":"199_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/viro.1998.9530","volume":"254","author":"K Okuma","year":"1999","unstructured":"Okuma K, Nakamura M, Nakano S, Niho Y, Matsuura Y. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology. 1999;254(2):235\u201344.","journal-title":"Virology"},{"issue":"1","key":"199_CR24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.0903846","volume":"185","author":"F Toulza","year":"2010","unstructured":"Toulza F, Nosaka K, Tanaka Y, Schioppa T, Balkwill F, Taylor GP, et al. Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol. 2010;185(1):183\u20139.","journal-title":"J Immunol"},{"issue":"6","key":"199_CR25","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-03-2068","volume":"64","author":"R Niwa","year":"2004","unstructured":"Niwa R, Shoji-Hosaka E, Sakurada M, Shinkawa T, Uchida K, Nakamura K, et al. Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. Cancer Res. 2004;64(6):2127\u201333.","journal-title":"Cancer Res"},{"issue":"22","key":"199_CR26","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-04-0983","volume":"10","author":"T Ishida","year":"2004","unstructured":"Ishida T, Iida S, Akatsuka Y, Ishii T, Miyazaki M, Komatsu H, et al. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia\/lymphoma. Clin Cancer Res. 2004;10(22):7529\u201339.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"199_CR27","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.4049\/jimmunol.0900699","volume":"183","author":"A Ito","year":"2009","unstructured":"Ito A, Ishida T, Utsunomiya A, Sato F, Mori F, Yano H, et al. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD\/Shi-scid, IL-2R\u03b3null mice in vivo. J Immunol. 2009;183(7):4782\u201391.","journal-title":"J Immunol."},{"issue":"5","key":"199_CR28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","volume":"16","author":"T Ishii","year":"2010","unstructured":"Ishii T, Ishida T, Utsunomiya A, Inagaki A, Yano H, Komatsu H, et al. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma. Clin Cancer Res. 2010;16(5):1520\u201331.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"199_CR29","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","volume":"28","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010;28(9):1591\u20138.","journal-title":"J Clin Oncol"},{"issue":"8","key":"199_CR30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30(8):837\u201342.","journal-title":"J Clin Oncol"},{"issue":"5","key":"199_CR31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/cas.12116","volume":"104","author":"T Ishida","year":"2013","unstructured":"Ishida T, Ito A, Sato F, Kusumoto S, Iida S, Inagaki H, et al. Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia\/lymphoma. Cancer Sci. 2013;104(5):647\u201350.","journal-title":"Cancer Sci"},{"issue":"3","key":"199_CR32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/1346-8138.12419","volume":"41","author":"K Yonekura","year":"2014","unstructured":"Yonekura K, Kanzaki T, Gunshin K, Kawakami N, Takatsuka Y, Nakano N, et al. Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis. J Dermatol. 2014;41(3):239\u201344.","journal-title":"J Dermatol"},{"issue":"3","key":"199_CR33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/hepr.12117","volume":"44","author":"N Nakano","year":"2014","unstructured":"Nakano N, Kusumoto S, Tanaka Y, Ishida T, Takeuchi S, Takatsuka Y, et al. Reactivation of hepatitis B virus in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab. Hepatol Res. 2014;44(3):354\u20137.","journal-title":"Hepatol Res"},{"issue":"3","key":"199_CR34","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.4049\/jimmunol.179.3.1996","volume":"179","author":"D Baatar","year":"2007","unstructured":"Baatar D, Olkhanud P, Newton D, Sumitomo K, Biragyn A. CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors. J Immunol. 2007;179(3):1996\u20132004.","journal-title":"J Immunol"},{"issue":"50","key":"199_CR35","doi-asserted-by":"crossref","first-page":"31831","DOI":"10.1016\/S0021-9258(18)31770-8","volume":"269","author":"NM Inocencio","year":"1994","unstructured":"Inocencio NM, Moehring JM, Moehring TJ. Furin activates Pseudomonas exotoxin A by specific cleavage in vivo and in vitro. J Biol Chem. 1994;269(50):31831\u20135.","journal-title":"J Biol Chem"},{"issue":"11","key":"199_CR36","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1172\/JCI31499","volume":"117","author":"W Ornatowski","year":"2007","unstructured":"Ornatowski W, Poschet JF, Perkett E, Taylor-Cousar JL, Deretic V. Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity. J Clin Invest. 2007;117(11):3489\u201397.","journal-title":"J Clin Invest"},{"issue":"Pt 3","key":"199_CR37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1242\/jcs.107.3.719","volume":"107","author":"TE Willnow","year":"1994","unstructured":"Willnow TE, Herz J. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. J Cell Sci. 1994;107(Pt 3):719\u201326.","journal-title":"J Cell Sci"},{"issue":"8","key":"199_CR38","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1128\/IAI.63.8.2912-2918.1995","volume":"63","author":"D Mucci","year":"1995","unstructured":"Mucci D, Forristal J, Strickland D, Morris R, Fitzgerald D, Saelinger CB. Level of receptor-associated protein moderates cellular susceptibility to pseudomonas exotoxin A. Infect Immun. 1995;63(8):2912\u20138.","journal-title":"Infect Immun"},{"issue":"9","key":"199_CR39","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/JVI.77.9.5286-5294.2003","volume":"77","author":"MZ Dewan","year":"2003","unstructured":"Dewan MZ, Terashima K, Taruishi M, Hasegawa H, Ito M, Tanaka Y, et al. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID\/\u03b3cnull mice: suppression by an inhibitor against NF-\u03baB. J Virol. 2003;77(9):5286\u201394.","journal-title":"J Virol"},{"issue":"4","key":"199_CR40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/1521-4141(200104)31:4<1037::AID-IMMU1037>3.0.CO;2-#","volume":"31","author":"A Lavareille de","year":"2001","unstructured":"de Lavareille A, Roufosse F, Schanden\u00e9 L, Stordeur P, Cogan E, Goldman M. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. Eur J Immunol. 2001;31(4):1037\u201346.","journal-title":"Eur J Immunol"},{"issue":"6188","key":"199_CR41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/335369a0","volume":"335","author":"VK Chaudhary","year":"1988","unstructured":"Chaudhary VK, Mizukami T, Fuerst TR, FitzGerald DJ, Moss B, Pastan I, et al. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein. Nature. 1988;335(6188):369\u201372.","journal-title":"Nature"},{"issue":"2","key":"199_CR42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.95.2.669","volume":"95","author":"PS Chowdhury","year":"1998","unstructured":"Chowdhury PS, Viner JL, Beers R, Pastan I. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity. Proc Natl Acad Sci USA. 1998;95(2):669\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"199_CR43","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1111\/j.1742-4658.2011.08182.x","volume":"278","author":"JE Weldon","year":"2011","unstructured":"Weldon JE, Pastan I. A guide to taming a toxin: recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer. FEBS J. 2011;278(23):4683\u2013700.","journal-title":"FEBS J"},{"issue":"8","key":"199_CR44","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1200\/JCO.2000.18.8.1622","volume":"18","author":"RJ Kreitman","year":"2000","unstructured":"Kreitman RJ, Wilson WH, White JD, Stetler-Stevenson M, Jaffe ES, Giardina S, et al. Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies. J Clin Oncol. 2000;18(8):1622\u201336.","journal-title":"J Clin Oncol"},{"issue":"20","key":"199_CR45","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1158\/0008-5472.CAN-11-1374","volume":"71","author":"DJ FitzGerald","year":"2011","unstructured":"FitzGerald DJ, Wayne AS, Kreitman RJ, Pastan I. Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates. Cancer Res. 2011;71(20):6300\u20139.","journal-title":"Cancer Res"},{"key":"199_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-6-1","volume":"6","author":"JD Mellor","year":"2013","unstructured":"Mellor JD, Brown MP, Irving HR, Zalcberg JR, Dobrovic A. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer. J Hematol Oncol. 2013;6:1.","journal-title":"J Hematol Oncol"},{"key":"199_CR47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fimmu.2014.00674","volume":"5","author":"SQ Nagelkerke","year":"2015","unstructured":"Nagelkerke SQ, Kuijpers TW. Immunomodulation by IVIg and the role of Fc-Gamma receptors: classic mechanisms of action after all? Front Immunol. 2015;5:674.","journal-title":"Front Immunol"},{"issue":"23","key":"199_CR48","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1073\/pnas.1405153111","volume":"111","author":"R Mazor","year":"2014","unstructured":"Mazor R, Eberle JA, Hu X, Vassall AN, Onda M, Beers R, et al. Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. Proc Natl Acad Sci USA. 2014;111(23):8571\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7210","key":"199_CR49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature07210","volume":"455","author":"M Pesu","year":"2008","unstructured":"Pesu M, Watford WT, Wei L, Xu L, Fuss I, Strober W, et al. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature. 2008;455(7210):246\u201350.","journal-title":"Nature"},{"issue":"8","key":"199_CR50","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/JVI.63.8.3220-3226.1989","volume":"63","author":"K Nagata","year":"1989","unstructured":"Nagata K, Ohtani K, Nakamura M, Sugamura K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line Jurkat. J Virol. 1989;63(8):3220\u20136.","journal-title":"J Virol"},{"issue":"2","key":"199_CR51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1872-034X.2012.01051.x","volume":"43","author":"Y Chen","year":"2013","unstructured":"Chen Y, Xie X, Gu L, Huang XH, Peng XM. Furin mRNA expression in peripheral blood correlates with chronic hepatitis B virus infection. Hepatol Res. 2013;43(2):208\u201316.","journal-title":"Hepatol Res"},{"issue":"Suppl 1","key":"199_CR52","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00042560-199600001-00015","volume":"13","author":"L Delamarre","year":"1996","unstructured":"Delamarre L, Rosenberg AR, Pique C, Pham D, Callebaut I, Dokh\u00e9lar MC. The HTLV-I envelope glycoproteins: structure and functions. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl 1):S85\u201391.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"Pt 4","key":"199_CR53","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-82-4-821","volume":"82","author":"K Okuma","year":"2001","unstructured":"Okuma K, Matsuura Y, Tatsuo H, Inagaki Y, Nakamura M, Yamamoto N, et al. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins. J Gen Virol. 2001;82(Pt 4):821\u201330.","journal-title":"J Gen Virol"},{"issue":"15","key":"199_CR54","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1128\/JVI.77.15.8562-8569.2003","volume":"77","author":"K Okuma","year":"2003","unstructured":"Okuma K, Dalton KP, Buonocore L, Ramsburg E, Rose JK. Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin. J Virol. 2003;77(15):8562\u20139.","journal-title":"J Virol"},{"issue":"5","key":"199_CR55","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood.V70.5.1407.1407","volume":"70","author":"M Maeda","year":"1987","unstructured":"Maeda M, Arima N, Daitoku Y, Kashihara M, Okamoto H, Uchiyama T, et al. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood. 1987;70(5):1407\u201311.","journal-title":"Blood"},{"issue":"2","key":"199_CR56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.2910340213","volume":"34","author":"K Sugamura","year":"1984","unstructured":"Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer. 1984;34(2):221\u20138.","journal-title":"Int J Cancer"},{"issue":"5843","key":"199_CR57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","volume":"294","author":"I Miyoshi","year":"1981","unstructured":"Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981;294(5843):770\u20131.","journal-title":"Nature"},{"issue":"3","key":"199_CR58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.V55.3.409.409","volume":"55","author":"AF Gazdar","year":"1980","unstructured":"Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, et al. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980;55(3):409\u201317.","journal-title":"Blood"},{"key":"199_CR59","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/bcj.2013.30","volume":"3","author":"E Ikebe","year":"2013","unstructured":"Ikebe E, Kawaguchi A, Tezuka K, Taguchi S, Hirose S, Matsumoto T, et al. Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice. Blood Cancer J. 2013;3:e132.","journal-title":"Blood Cancer J"},{"issue":"9","key":"199_CR60","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/\u03b3 c null mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175\u201382.","journal-title":"Blood"},{"issue":"5","key":"199_CR61","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12185-008-0215-z","volume":"88","author":"S Okada","year":"2008","unstructured":"Okada S, Harada H, Ito T, Saito T, Suzu S. Early development of human hematopoietic and acquired immune systems in new born NOD\/Scid\/Jak3null mice intrahepatic engrafted with cord blood-derived CD34+ cells. Int J Hematol. 2008;88(5):476\u201382.","journal-title":"Int J Hematol"},{"issue":"1","key":"199_CR62","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.87.1.308","volume":"87","author":"VK Chaudhary","year":"1990","unstructured":"Chaudhary VK, Jinno Y, FitzGerald D, Pastan I. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc Natl Acad Sci USA. 1990;87(1):308\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"199_CR63","doi-asserted-by":"crossref","first-page":"17376","DOI":"10.1016\/S0021-9258(19)47383-3","volume":"266","author":"S Seetharam","year":"1991","unstructured":"Seetharam S, Chaudhary VK, FitzGerald D, Pastan I. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J Biol Chem. 1991;266(26):17376\u201381.","journal-title":"J Biol Chem."},{"issue":"7","key":"199_CR64","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood-2004-09-3646","volume":"106","author":"M Watanabe","year":"2005","unstructured":"Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, et al. Dual targeting of transformed and untransformed HTLV-1\u2013infected T cells by DHMEQ, a potent and selective inhibitor of NF-\u03baB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood. 2005;106(7):2462\u201371.","journal-title":"Blood"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-015-0199-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T16:43:49Z","timestamp":1653065029000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.retrovirology.com\/content\/12\/1\/73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,20]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1186\/s12977-015-0199-8","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,20]]},"article-number":"73"}}